SHARE

As per the report published by Fior Markets, the global sciatica treatment market is expected to grow from USD XX Million in 2018 to USD XX Million by 2026 at a CAGR of XX% during the forecast period from 2019-2026. High expenditure on the healthcare especially of the U.S. and Canada, presence of major players, awareness about the diseases, and rapid technological advancements are some of the factors that led to the growth of sciatica treatment market in North America region.

Sciatica Treatment Market by Treatment Type (Drug Treatment, Non-Drug Treatment), End User (Hospitals, Surgical Centers, Others), Region and Global Forecast 2019-2026.

DOWNLOAD FREE SAMPLE REPORT:https://www.fiormarkets.com/report-detail/386035/request-sample

Prominent companies in the industry include Endo Pharmaceuticals, AstraZeneca, Novartis AG, Teva Pharmaceutical Industries, Neurotech, Nidd Valley Medical, Omega Laser Systems Ltd., Omron Healthcare, Inc., Sanofi, Johnson & Johnson Services, Inc. and among others are offering greater opportunities and major players are continuously focused on new product developments and venture capital investments to obtain market share.

Treatment type segment covers drug treatment and non-drug treatment. The drug treatment segment is further divided into steroids, painkillers, antidepressants, muscle relaxants, and anesthetics. The non-drug treatment segment is further classified into acupuncture, stimulation device, and physiotherapy. The drug treatment segment held the highest market share in the global sciatica treatment market owing to the ease of consumption, safer to handle, and easy availability. End user segment is divided into hospitals, surgical centers, and others. The hospitals segment is anticipated to grow with the highest growth rate during the forecast period owing to hospitals having good reimbursement rate and availability of skilled doctors and surgeons.

BROWSE COMPLETE REPORT AND TABLE OF CONTENTS:https://www.fiormarkets.com/report/sciatica-treatment-market-by-treatment-type-drug-treatment-386035.html

Increase in safety and success of drug treatment, increasing geriatrics cases and screenings, and rising excruciating pain among peoples are the key driving factors for the sciatica treatment market. The high cost of treatment and several difficulties in the sciatic surgery may limit the growth of market. However, lack of awareness about the disease in the underdeveloped countries is expected to boost the sciatica treatment market over the forecast period.

Customization of the Report:This report can be customized to meet the client’s requirements. Please connect with our sales team (sales@fiormarkets.com), who will ensure that you get a report that suits your needs.